Health
Biomarkers that are predictive of clinical benefit in Trop-2-expressing triple-negative breast cancer – News-Medical.Net
Oncotarget recently published “Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer” which reported that…
Reviewed by Emily Henderson, B.Sc.Nov 3 2020
Oncotarget recently published “Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer” which reported that the authors investigated whether Trop-2-expression and homologous recombination repair of SN-38-mediated double-strand DNA breaks play a role in the sensitivity of triple-negative breast cancer to SG.
Further, two Trop-2-transfectants of MDA-MB-231, C13, and C39, were treated in mice with SG to…
-
Noosa News21 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News11 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News16 hours agoManjimup engineer turns previously wasted avocados into liquid gold
-
Noosa News11 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher